Safety of Ertapenem in Beta-lactam Allergic Patients.

• Status: Unknown status
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess cross-reactivity and tolerability of ertapenem in patients with IgE-mediated allergy to at least one beta-lactam molecule.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Catholic University of the Sacred Heart
• Collaborator: Merck Sharp & Dohme Corp.
• Treatments: beta-Lactams; Ertapenem; Lactams

Criteria

Inclusion Criteria:

• IgE-mediated allergy to at least one beta-lactam molecule

Exclusion Criteria:

• positive allergy testing to ertapenem

• chronic diseases

• treatment with beta-blockers

• pregnancy